Michael R. Conroy

Oncology

1101 Hempstead Tpke
Uniondale, NY 11553

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Emergence of Microsatellite Instability in an Oncogene-Driven Non-Small Cell Lung Cancer Harboring a Canonical EGFR Mutation: A Molecular Tumor Board Discussion.

Emergence of Microsatellite Instability in an Oncogene-Driven Non-Small Cell Lung Cancer Harboring a Canonical EGFR Mutation: A Molecular Tumor Board Discussion.

Journal: JCO precision oncology

Published: July 01, 2026

Primary resistance to ICI-based regimens is associated with early longitudinal changes in the fecal microbiome and loss of microbial stability.

Primary resistance to ICI-based regimens is associated with early longitudinal changes in the fecal microbiome and loss of microbial stability.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer.

Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer.

Journal: Cancer research communications

Published: September 15, 2025

Novel Predictive Spatial Biomarker in Non-Small Cell Lung Carcinoma: The Diversity of Niches Unlocking Treatment Sensitivity (DONUTS).

Novel Predictive Spatial Biomarker in Non-Small Cell Lung Carcinoma: The Diversity of Niches Unlocking Treatment Sensitivity (DONUTS).

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2025

Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study.

Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 13, 2025

Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survival.

Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survival.

Journal: Cancer

Published: February 27, 2025

Immunotherapy for resectable lung cancer.

Immunotherapy for resectable lung cancer.

Journal: Cancer

Published: September 16, 2024

Neoadjuvant chemoradiation in older Irish adult patients with oesophageal cancer: a retrospective institutional review of clinical outcomes and hematological toxicity.

Neoadjuvant chemoradiation in older Irish adult patients with oesophageal cancer: a retrospective institutional review of clinical outcomes and hematological toxicity.

Journal: BMC cancer

Published: August 06, 2024

Exploring the prognostic impact of absolute lymphocyte count in patients treated with immune-checkpoint inhibitors.

Exploring the prognostic impact of absolute lymphocyte count in patients treated with immune-checkpoint inhibitors.

Journal: BJC reports

Published: September 04, 2023

Tracing the genetic fingerprints of tumour evolution: The pursuit of identifying mutations with differential weights within the overall tumour mutation burden and their role in therapeutic responses with immune checkpoint blockade.

Tracing the genetic fingerprints of tumour evolution: The pursuit of identifying mutations with differential weights within the overall tumour mutation burden and their role in therapeutic responses with immune checkpoint blockade.

Journal: Clinical and translational medicine

Published: May 12, 2023

Advancing neoadjuvant immunotherapy for lung cancer.

Advancing neoadjuvant immunotherapy for lung cancer.

Journal: Nature medicine

Published: March 17, 2023

Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer.

Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 31, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026